Product NDC: | 25021-128 |
Proprietary Name: | Ceftazidime |
Non Proprietary Name: | ceftazidime |
Active Ingredient(s): | 2 g/1 & nbsp; ceftazidime |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-128 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062640 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080515 |
Package NDC: | 25021-128-50 |
Package Description: | 10 VIAL in 1 CARTON (25021-128-50) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 25021-128-50 |
Proprietary Name | Ceftazidime |
Package Description | 10 VIAL in 1 CARTON (25021-128-50) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 25021-128 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ceftazidime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080515 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | CEFTAZIDIME |
Strength Number | 2 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |